{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-250822","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2023-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.580041+00:00","generated_at":"2026-06-10T04:55:52.881884+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ALX Oncology reports preliminary Q3 2023 cash position of $196.5M","bullets":["Preliminary cash, cash equivalents, and investments of $196.5M as of Sep 30, 2023, subject to quarter-end close.","Estimate is unaudited and may change upon completion of financial statement closing procedures.","No other Q3 financial results released; full report expected later."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-250822","json":"https://secwatch.observer/filing/0001193125-23-250822.json","markdown":"https://secwatch.observer/filing/0001193125-23-250822.md","text":"https://secwatch.observer/filing/0001193125-23-250822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312523250822/0001193125-23-250822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312523250822/d537542d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:55:52.881884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e28675aa367579384c33d78c9b63e6269279edb8","claim":"ALX ONCOLOGY HOLDINGS INC reported preliminary financial results for the third quarter ended September 30, 2023.","evidence_excerpt":"ALX Oncology Holdings Inc. (the “Company”), announced its preliminary estimate of cash, cash equivalents and short-term and long-term investments for the third quarter ended September 30, 2023. Based upon preliminary estimates and information available to the Company as of the date of this Form 8-K, it had approximately $196.5 million of cash, cash equivalents and short-term and long-term investments as of September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312523250822/0001193125-23-250822-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}